Developing Cyclic Opioid Analogues: Fluorescently Labeled Bioconjugates of Biphalin

Area of Science:

• Medicinal Chemistry
• Bioconjugate Development
• Pharmacology

Background:

• Bioconjugates are crucial in medicinal chemistry for targeted therapies and controlled drug release.
• Opioid peptides are vital for pain management and neurological research.

Purpose of the Study:

• To synthesize and characterize novel fluorescently labeled opioid peptides.
• To evaluate their binding affinity and functional potency for opioid receptors.
• To explore their potential for medical and biological applications.

Main Methods:

• Synthesis of three novel cyclic biphalin derivative analogues.
• Fluorescent labeling with a dansyl-maleimide motif.
• Binding affinity and functional potency assays for opioid receptors.
• Fluorescence emission spectrum analysis.

Main Results:

• Successful synthesis and characterization of compounds 1D, 1C, and 2C.
• Compound 1D demonstrated excellent binding affinity and functional potency for the delta-opioid receptor (DOR).
• Compound 1D exhibited a strong fluorescence emission spectrum (300-700 nm).

Conclusions:

• Compound 1D is a promising fluorescent probe for targeting the DOR.
• Its properties are suitable for in vivo imaging and the development of new diagnostic tools.
• This work provides a lead for designing novel fluorescent probes for opioid receptor research.